A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer
Clinical trial NCT03941873 · COMPLETED
Trial details
- NCT number
- NCT03941873
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-28
- Primary completion
- 2023-03-31
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.